Making Europe’s salesforces leaner and meaner

April 26, 2007
Sales and Marketing Europe, representatives, sales, strategy

The world of pharma salesforce management is witnessing a serious move away from mass detailing to a system based on …

UK science at a ‘tipping point’

April 26, 2007
Research and Development

The future for the UK's medical science base looks very bright, according to leading figures in the government, science and …

Januvia launched in UK

April 25, 2007
Sales and Marketing Januvia, diabetes

Merck Sharp & Dohme has launched its first-in-class diabetes treatment Januvia in the UK. Januvia has been approved as an …

Free healthcare a ‘mirage’ in UK

April 25, 2007
Sales and Marketing Doctors for reform

 UK patients routinely top up their care by going private, undermining politicians’ claims the NHS is free-to-all, according to a …

AZ’s latest purchase fails to impress investors

April 25, 2007
Sales and Marketing

AstraZeneca has entered the lucrative vaccine market and gained a range of potential new biologic products with the £15.6 billion …

Clinical trial news from Datamonitor

April 18, 2007
Research and Development

Array BioPharma receives payment for cancer inhibitorArray BioPharma has received a $2 million milestone payment from AstraZeneca after its MEK …

Product news roundup from Datamonitor

April 18, 2007
Sales and Marketing

Changing of the guard in HIV treatmentThe HIV market is forecast to grow from $7.1 billion in 2005 to an …

Lilly upbeat after strong start to year

April 18, 2007
Sales and Marketing

Stronger than expected sales and profits in early 2007 has lifted Lilly, prompting the US pharma company to raise its …

Public to get clearer picture of hospital bugs

April 18, 2007
NHS

 The government is to turn up the heat on trusts over rising levels of hospital infections by showing the public …

Diabetes drug costs double in five years

April 18, 2007
Sales and Marketing

A growing number of patients and a switch to newer medicines has brought about a doubling of England's spending on …

Athena wins two Pfizer accounts

April 18, 2007
Medical Communications

Athena Medical PR has been appointed by Pfizer UK to run its PR campaigns for two of its anti-infective products: …

Europe’s buoyant biotech set for further growth

April 16, 2007
Research and Development, Sales and Marketing biotech

A new comprehensive survey of the world's biotechnology industry shows the sector to be in great health, with indications of …

NICE in the dock: what the judicial review means for pharma

April 16, 2007
Research and Development, Sales and Marketing NICE, UK, healthcare, judicial review

The National Institute for Health and Clinical Excellence (NICE) has been at the centre of controversy ever since its inception …

Product news from Datamonitor

April 16, 2007
Research and Development, Sales and Marketing

Carrington Laboratories to manufacture sublingual vaccinesCarrington Laboratories has reported that its subsidiary DelSite Biotechnologies has entered into an agreement with …

Company news from Datamonitor

April 16, 2007
Sales and Marketing

Avenir plans restructure and ends AZ collaborationsAvanir Pharmaceuticals has said it plans to implement a restructuring plan and has ended …

NHS will be ‘unrecognisable’ in 10 years’ time, say doctors

April 16, 2007
NHS

Most young doctors believe the NHS will be unrecognisable in 10 years' time, a new survey has revealed.The research, published …

Europe imposes restrictions on Ketek prescribing

April 16, 2007
Sales and Marketing Ketek, safety

The European Medicines Agency has issued guidance for the four indications of Ketek, the Sanofi-Aventis antibiotic stripped of several indications …

Encouraging New Thinking in Strategic Planning

April 12, 2007
Sales and Marketing marketing, planning, strategic planning, strategy

How many pharma marketers, faced with the annual chore of writing a strategic plan, have decided not to take the …

Product Development Update

April 12, 2007
Research and Development, Sales and Marketing

Product news round-up from Datamonitor ChemGenex begins CML trialChemGenex Pharmaceutical has treated the first patient in a new phase II/III clinical …

Change in US law could cut drugs spending by $30 billion

April 12, 2007
Sales and Marketing US, reform

Calls to allow the US government to negotiate drug prices with the pharmaceutical industry have been reawakened by a new …

The Gateway to Local Adoption Series

Latest content